Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Angeliq 1mg/2mg Tablet – PA1410/013/001
- Celebrex 100mg Hard Capsule – PA0822/116/001
- Celebrex 200mg Hard Capsule – PA0822/116/002
- Efexor XL 37.5mg Prolonged Release Capsule – PA0822/072/001
- Epanutin 300mg Hard Capsule – PA0822/011/004
- Erythrocin 250mg Tablet – PA1142/008/002
- Geodon 80mg Capsule – PA0822/214/004
The following shortage has been resolved and supply has resumed to the Irish market:
- Antabuse 400mg Effervescent Tablet – PA1380/008/001
- Cibacen 5mg Film Coated Tablet – PA2010/029/001
- Cozaar 12.5mg Film Coated Tablet – PA1286/004/001
- Dexsol 2mg/5ml Oral Solution – PA22741/003/001
- Difene 25mg Capsule – PA2256/001/001
- Genotropin 5.3mg Powder and Solvent for Solution for Injection – PA0822/128/001
- Keflex 500mg Capsule - PA1126/002/004
- Pneumovax 23 Solution for Injection in Prefilled Syringe – PA1286/055/002
- Rebetol 40mg/ml Oral Solution – EU/1/99/107/004
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.